prednisolone has been researched along with B16 Melanoma in 11 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tumor-associated inflammation has been recognized as an important tumor growth propagator and, therefore, represents an attractive target for anti-cancer therapy." | 1.37 | Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity. ( Boekhoven, RW; Kluza, E; Nicolay, K; Schiffelers, RM; Schmid, S; Storm, G; Strijkers, GJ; van der Schaft, DW; Yeo, SY, 2011) |
| " The antitumor effects of the free drugs have only been observed using treatment schedules based on high and frequent dosing for prolonged periods of time." | 1.33 | Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. ( Fens, MH; Janssen, AP; Metselaar, JM; Molema, G; Schiffelers, RM; Storm, G, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Licarete, E | 2 |
| Rauca, VF | 2 |
| Luput, L | 2 |
| Patras, L | 2 |
| Sesarman, A | 2 |
| Banciu, M | 6 |
| Drotar, D | 1 |
| Stejerean, I | 1 |
| Dume, B | 1 |
| Toma, VA | 1 |
| Porfire, A | 1 |
| Gherman, C | 1 |
| Smits, EAW | 1 |
| Soetekouw, JA | 1 |
| Pieters, EHE | 1 |
| Smits, CJP | 1 |
| de Wijs-Rot, N | 1 |
| Vromans, H | 1 |
| Metselaar, JM | 4 |
| Schiffelers, RM | 6 |
| Storm, G | 7 |
| Kluza, E | 1 |
| Yeo, SY | 1 |
| Schmid, S | 1 |
| van der Schaft, DW | 1 |
| Boekhoven, RW | 1 |
| Strijkers, GJ | 1 |
| Nicolay, K | 1 |
| Cittadino, E | 1 |
| Ferraretto, M | 1 |
| Torres, E | 1 |
| Maiocchi, A | 1 |
| Crielaard, BJ | 1 |
| Lammers, T | 1 |
| Aime, S | 1 |
| Terreno, E | 1 |
| Fens, MH | 3 |
| Janssen, AP | 1 |
| Molema, G | 1 |
| Musch, E | 1 |
| Malek, M | 1 |
| Peter-Katalinic, J | 1 |
| Egge, H | 1 |
| Rink, H | 1 |
| Lathan, B | 1 |
| Riedel, E | 1 |
11 other studies available for prednisolone and B16 Melanoma
| Article | Year |
|---|---|
The prednisolone phosphate‑induced suppression of the angiogenic function of tumor‑associated macrophages enhances the antitumor effects of doxorubicin on B16.F10 murine melanoma cells in vitro.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug | 2019 |
Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Doxorubicin; Liposomes; Macrophages; M | 2020 |
The availability of drug by liposomal drug delivery : Individual kinetics and tissue distribution of encapsulated and released drug in mice after administration of PEGylated liposomal prednisolone phosphate.
Topics: Animals; Apoptosis; Cell Proliferation; Disease Models, Animal; Drug Delivery Systems; Drug Liberati | 2019 |
Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice.
Topics: Animals; Budesonide; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic N | 2008 |
Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; Glucocorticoids; Humans; | 2011 |
MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Contrast Media; Gadolinium; Glucocorticoids; Lipos | 2012 |
Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.
Topics: Animals; Cell Proliferation; Colonic Neoplasms; Endothelial Cells; Liposomes; Male; Melanoma, Experi | 2005 |
Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Colonic Neoplasms; Dr | 2006 |
Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue.
Topics: Animals; Antineoplastic Agents; Clodronic Acid; Liposomes; Macrophages; Male; Melanoma, Experimental | 2008 |
Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.
Topics: Animals; Antineoplastic Agents; Budesonide; Dexamethasone; Dose-Response Relationship, Drug; Liposom | 2008 |
Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.
Topics: Animals; Carcinoma; Chlorambucil; Chromatography, High Pressure Liquid; Colonic Neoplasms; Mammary N | 1992 |